M&T Bank
BBIO icon

M&T Bank’s BridgeBio Pharma BBIO Stock Holding History

M&T Bank’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$519K Sell
6,988
-16
-0.2% -$1.16K ﹤0.01% 1099
2025
Q4 		$536K Buy
+7,004
New +$460K ﹤0.01% 1091
2021
Q1 		– Sell
-5,319
Closed -$378K – 1573
2020
Q4 		$378K Sell
5,319
-931
-15% -$44.9K ﹤0.01% 1212
2020
Q3 		$235K Hold
6,250
– – ﹤0.01% 1349
2020
Q2 		$204K Buy
+6,250
New +$190K ﹤0.01% 1374
2020
Q1 		– Sell
-7,000
Closed -$245K – 1567
2019
Q4 		$245K Buy
+7,000
New +$194K ﹤0.01% 1175

Other funds holding BBIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return